## 



## 

## 

## 



## 

## 

||Page|
|---|---|
|Trustees' report|1 -2|
|Independent examiner's report|3|
|Statement of financial activities|4|
|Balance sheet|5|
|Statement of cash flows|6|
|Notes to the financial statements|7-12|





## 

## 

## 

## 

## 

## 

## 

## 



## 

## 




4/2/2025 



## 

## 

## 

|||**Unrestricted**|**Unrestricted**|
|---|---|---|---|
|||**funds**|funds|
|||**2024**|2023|
||**Notes**|£|£|
|**Income** **from:**||||
|Donations and legacies|**2**||4,100,000|
|Investments|**3**||15,032|
|**Total** **income**|||4,115,032|
|**Expenditure** **on:**||||
|Charitable activities|4|154,931|598,861|
|**Total** **expenditure**||154,931|598,861|
|Net gains/(losses) on investments|**8**||(81,056)|
|**Net** **income/(expenditure)**||(154,931)|3,435,115|
|**Other** **recognised** **gains** **and** **losses:**||||
|Other losses|10|(5,662)|(149,030)|
|**Net** **movement** **in** **funds**||(160,593)|3,286,085|
|**Reconciliation** **of** **funds:**||||
|Fund balances at 6 April 2023||4,220,902|934,817|
|**Fund** **balances** **at** **5** **April** **2024**||4,060,309|4,220,902|





## 

## 

## 

|||**2024**||**2023**||
|---|---|---|---|---|---|
||**Notes**|**£**|**£**|**£**|**£**|
|**Current** **assets**||||||
|Debtors|11|4,000,000||4,000,000||
|Cash at bank and in hand||82,411||263,522||
|||4,082,411||4,263,522||
|**Creditors:** **amounts** **falling** **due** **within**|**12**|||||
|**one** **year**||(22,102)||(42,620)||
|**Net** **current** **assets**|||4,060,309||4,220,902|
|**The** **funds** **of** **the** **Foundation**||||||
|Unrestricted funds|13||4,060,309||4,220,902|
||||4,060,309||4,220,902|



## 



## 

## 

## 

||||2024|||2023||
|---|---|---|---|---|---|---|---|
||Notes|£||£|£||£|
|Cash flows from operating activities||||||||
|Cash absorbed by operations|16|||(181,111)|||(608,271)|
|Investing activities||||||||
|Proceeds from disposal of investments|||||856,761|||
|Investment income received|||||15,032|||
|Net cash generated from investing activities|||||||871,793|
|Net cash generated from financing activities||||||||
|Net (decrease)/increase in cash and cash <br>equivalents||||(181,111)|||263,522|
|Cash and cash equivalents at beginning of year||||263,522||||
|Cash and cash equivalents at end of year||||82,411|||263,522|





## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

||Unrestricted|Unrestricted|
|---|---|---|
||funds|funds|
||2024|2023|
||£|£|
|Donations and gifts||100,000|
|Legacies||4,000,000|
|||4,100,000|



||Unrestricted|Unrestricted|
|---|---|---|
||funds|funds|
||2024|2023|
||£|£|
|Income from listed investments||15,032|





## 

## 

## 

## 

|||**2024**|**2023**|
|---|---|---|---|
|||**£**|**£**|
||**Direct** **costs**|||
||Audit fees||3,600|
||Legal fees|16,500|15,000|
||Tax preparation fees|1,122|1,020|
||Independent examination fees|3,350||
|||20,972|19,620|
||Grant funding of activities (see note 5)|||
||**Analysis** **by** **fund**|||
||Unrestricted funds|154,931|598,861|
|**5**|**Grants** **payable**|||
|||**2024**|**2023**|
|||**£**|**£**|
||Grants to institutions:|||
||Other|133,959|579,241|



## 

## 

||**2024**|**2023**|
|---|---|---|
||**Number**|**Number**|
|Total|||



## 



## 

## 

## 

## 

||**Unrestricted**|**Unrestricted**|
|---|---|---|
||**funds**|**funds**|
||**2024**|**2023**|
|Gains/(losses) arising on:|£|£|
|Revaluation of investments||(81,056)|



## 

## 

|**Other** **gains** **or** **losses**|||
|---|---|---|
||**Unrestricted**|**Unrestricted**|
||**funds**|**funds**|
||**2024**|**2023**|
||£|£|
|Foreign exchange (gains)/losses|5,662|149,030|
|**Debtors**|||
||**2024**|**2023**|
|**Amounts** **falling** **due** **within** **one** **year:**|£|£|
|Other debtors|4,000,000|4,000,000|



## 

|**12**|**Creditors:** **amounts** **falling** **due** **within** **one** **year**|||
|---|---|---|---|
||Grants outstanding<br>Accruals and deferred income|||
|||22,102|42,620|





## 

## 

## 

## 

||**At** **6** **April**|**Incoming**|**Resources**|**Gains** **and**|**At** **5** **April**|
|---|---|---|---|---|---|
||**2023**|**resources**|**expended**|**losses**|**2024**|
||**£**|**£**|**£**|**£**|**£**|
|General funds|4,220,902||(154,931)|(5,662)|4,060,309|
|**Previous** **year:**|**At** **6** **April**|**Incoming**|**Resources**|**Gains** **and**|**At** **5** **April**|
||**2022**|**resources**|**expended**|**losses**|**2023**|
||**£**|**£**|**£**|**£**|£|
|General funds|934,817|4,115,032|(598,861)|(230,086)|4,220,902|



## 

||**Unrestricted**|
|---|---|
||**funds**|
||**2024**|
||**£**|
|**At** **5** **April** **2024:**||
|Current assets/(liabilities)|4,060,309|
||4,060,309|
||**Unrestricted**|
||**funds**|
||**2023**|
||**£**|
|**At** **5** **April** **2023:**||
|Current assets/(liabilities)|4,220,902|
||4,220,902|





## 

## 

## 

|**16**|**Cash** **absorbed** **by** **operations**|**2024**|**2023**|
|---|---|---|---|
|||£|£|
||(Deficit)/surplus for the year|(154,931)|3,435,115|
||**Adjustments** **for:**|||
||Investment income recognised in statement of financial activities||(15,032)|
||Foreign exchange differences|(5,662)|(149,030)|
||Fair value gains and losses on investments||81,056|
||**Movements** **in** working capital:|||
||(Increase) in debtors||(4,000,000)|
||(Decrease)/increase in creditors|(20,518)|39,620|
||**Cash** **absorbed** **by** **operations**|(181,111)|(608,271)|